title: Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats.
authors.affiliation: Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts 02115.
authors.forename: T
authors.initials: T
authors.lastname: Sablinski
authors.forename: M H
authors.initials: MH
authors.lastname: Sayegh
authors.forename: J P
authors.initials: JP
authors.lastname: Kut
authors.forename: W W
authors.initials: WW
authors.lastname: Hancock
authors.forename: E L
authors.initials: EL
authors.lastname: Milford
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
authors.forename: J W
authors.initials: JW
authors.lastname: Kupiec-Weglinski
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D003433:Crosses, Genetic; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D003524:Cyclosporins